{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:51:21Z","timestamp":1787003481145,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009564","name":"Health and Family Planning Commission of Sichuan Province","doi-asserted-by":"publisher","award":["17ZD015"],"award-info":[{"award-number":["17ZD015"]}],"id":[{"id":"10.13039\/501100009564","id-type":"DOI","asserted-by":"publisher"}]},{"name":"1\u20223\u20225 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan Universit"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cryptococcosis is a systemic infection and it may occur in immunocompromised and immunocompetent hosts. In order to better understand the clinical characteristics of patients with PC in different immune status, we retrospectively investigated the clinical, radiological, and treatment profiles of immunocompetent and immunocompromised patients with PC during a 10-year period (2008\u20132017). As a result, out of 136 patients, 94 (69.1%) were immunocompromised hosts. For the PC patients without CNS involvement, higher percentage of immunocompetent patients (39.5%, 15\/38) had asymptomatic presentation than immunocompromised patients (6.3%, 3\/48) (P\u2009&lt;\u20090.05). Multiple pulmonary nodules (72.7%, 56\/77), ground-glass attenuation\/interstitial changes (94.4%, 17\/18) and cavitation (88.6%, 31\/35) were significantly frequent in immunocompromised patients (P\u2009&lt;\u20090.05). A total of 47 patients were misdiagnosed as tuberculosis or tumors based on CT signs. PC was likely to be misdiagnosed as tuberculosis in immunocompromised patients (88.2%, 15\/17), and tumor was more likely to be considered in immunocompetent patients (43.3%, 13\/30). Immunocompetent patients accounted for 80% (24\/30) of patients with definite diagnosis on surgical lung biopsy. Fluconazole monotherapy can achieve good clinical outcome in most PC patients without central nervous system (CNS) involvement (91.5%, 54\/59). After 3 months of treatment, 92.7% (38\/41) patients have improved imaging findings. In conclusion, PC has diverse imaging manifestations and it is easily misdiagnosed. Lobectomy should be carefully selected in immunocompetent patients with a single lung lesion. Fluconazole monotherapy is preferred for PC patients without CNS involvement.<\/jats:p>","DOI":"10.1038\/s41598-020-66094-7","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T06:03:15Z","timestamp":1591768995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Clinical analysis in immunocompetent and immunocompromised patients with pulmonary cryptococcosis in western China"],"prefix":"10.1038","volume":"10","author":[{"given":"Junyan","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xijiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoju","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,10]]},"reference":[{"key":"66094_CR1","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","volume":"17","author":"R Rajasingham","year":"2017","unstructured":"Rajasingham, R. et al. Global burden of disease of HIV-associated cryptococcal meningitis: An updated analysis. Lancet Infect. Dis. 17, 873\u2013881 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"66094_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-019-01088-8","author":"X Sui","year":"2019","unstructured":"Sui, X. et al. Clinical features of pulmonary cryptococcosis in thin-section CT in immunocompetent and non-AIDS immunocompromised patients. Radiol. Med. https:\/\/doi.org\/10.1007\/s11547-019-01088-8 (2019).","journal-title":"Radiol. Med."},{"key":"66094_CR3","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1128\/IAI.00542-09","volume":"77","author":"R Velagapudi","year":"2009","unstructured":"Velagapudi, R., Hsueh, Y. P., Geunes-Boyer, S., Wright, J. R. & Heitman, J. Spores as infectious propagules of Cryptococcus neoformans. Infect. Immun. 77, 4345\u20134355 (2009).","journal-title":"Infect. Immun."},{"key":"66094_CR4","doi-asserted-by":"crossref","unstructured":"Galanis, E., Macdougall, L., Kidd, S. & Morshed, M., British Columbia Cryptococcus gattii Working Group. Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999\u20132007. Emerg. Infect. Dis. 16, 251\u2013257 (2010).","DOI":"10.3201\/eid1602.090900"},{"key":"66094_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.fgb.2015.02.009","volume":"78","author":"F Hagen","year":"2015","unstructured":"Hagen, F. et al. Recognition of seven species in the Cryptococcus gattii\/ Cryptococcus neoformans species complex. Fungal Genet. Biol. 78, 16\u201348 (2015).","journal-title":"Fungal Genet. Biol."},{"key":"66094_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11684-017-0601-0","volume":"12","author":"M Chen","year":"2018","unstructured":"Chen, M. et al. Epidemiology of fungal infections in China. Front. Med. 12, 58\u201375 (2018).","journal-title":"Front. Med."},{"key":"66094_CR7","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1183\/09031936.00168011","volume":"40","author":"Y Zhang","year":"2012","unstructured":"Zhang, Y. et al. Clinical analysis of 76 patients pathologically diagnosed with pulmonary cryptococcosis. Eur. Respir. J. 40, 1191\u2013200 (2012).","journal-title":"Eur. Respir. J."},{"key":"66094_CR8","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1093\/infdis\/jir152","volume":"203","author":"XT Ou","year":"2011","unstructured":"Ou, X. T. et al. Genotypes coding for mannose-binding lectin deficiency correlated with cryptococcal meningitisin HIV-uninfected Chinese patients. J. Infect. Dis. 203, 1686\u20131691 (2011).","journal-title":"J. Infect. Dis."},{"key":"66094_CR9","doi-asserted-by":"publisher","first-page":"e42439","DOI":"10.1371\/journal.pone.0042439","volume":"7","author":"XP Hu","year":"2012","unstructured":"Hu, X. P. et al. Association of Fc\u03b3 receptor IIB polymorphism with cryptococcal meningitis in HIV-uninfected Chinese patients. PLoS One 7, e42439 (2012).","journal-title":"PLoS One"},{"key":"66094_CR10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/13693780701390140","volume":"45","author":"J Meletiadis","year":"2007","unstructured":"Meletiadis, J. et al. Study of common functional genetic polymorphisms of FCGR2A, 3\u2009A and 3B genes and the risk for cryptococcosis in HIV-uninfected patients. Med. Mycol. 45, 513\u2013518 (2007).","journal-title":"Med. Mycol."},{"key":"66094_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.fgb.2014.10.017","volume":"78","author":"W Fang","year":"2015","unstructured":"Fang, W., Fa, Z. & Liao, W. Epidemiology of\u2002Cryptococcus and cryptococcosis in China. Fungal Genet. Biol. 78, 7\u201315 (2015).","journal-title":"Fungal Genet. Biol."},{"key":"66094_CR12","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/myc.12966","volume":"62","author":"X Hou","year":"2019","unstructured":"Hou, X. et al. Pulmonary cryptococcosis characteristics in immunocompetent patients-A 20-year clinicalretrospective analysis in China. Mycoses 62, 937\u2013944 (2019).","journal-title":"Mycoses"},{"key":"66094_CR13","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1086\/313757","volume":"30","author":"MS Saag","year":"2000","unstructured":"Saag, M. S. et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin. Infect. Dis. 30, 710\u2013718 (2000).","journal-title":"Clin. Infect. Dis."},{"key":"66094_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/649858","volume":"50","author":"JR Perfect","year":"2012","unstructured":"Perfect, J. R. et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin. Infect. Dis. 50, 291\u2013322 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"66094_CR15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.5812\/ijem.3505","volume":"10","author":"A Ghasemi","year":"2012","unstructured":"Ghasemi, A. & Zahediasl, S. Normality tests for statistical analysis: a guide for non-statisticians. Int. J. Endocrinol. Metab. 10, 486\u2013489 (2012).","journal-title":"Int. J. Endocrinol. Metab."},{"key":"66094_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ijid.2004.12.004","volume":"10","author":"S Kiertiburanakul","year":"2006","unstructured":"Kiertiburanakul, S., Wirojtananugoon, S., Pracharktam, R. & Sungkanuparph, S. Cryptococcosis in human immunodeficiency virus-negative patients. Int. J. Infect. Dis. 10, 72\u201378 (2006).","journal-title":"Int. J. Infect. Dis."},{"key":"66094_CR17","doi-asserted-by":"publisher","first-page":"e61921","DOI":"10.1371\/journal.pone.0061921","volume":"8","author":"HK Tseng","year":"2013","unstructured":"Tseng, H. K. et al. Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997\u20132010. PLoS One 8, e61921 (2013).","journal-title":"PLoS One"},{"key":"66094_CR18","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3201\/eid1405.071312","volume":"14","author":"J Chen","year":"2008","unstructured":"Chen, J. et al. Cryptococcus neoformans strains and infection in apparently immunocompetent patients, China. Emerg. Infect. Dis. 14, 755\u2013762 (2008).","journal-title":"Emerg. Infect. Dis."},{"key":"66094_CR19","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.21037\/jtd.2016.10.36","volume":"8","author":"K Liu","year":"2016","unstructured":"Liu, K. et al. Clinical analysis of non-AIDS patients pathologically diagnosed with pulmonary cryptococcosis. J. Thorac. Dis. 8, 2813\u20132821 (2016).","journal-title":"J. Thorac. Dis."},{"key":"66094_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11046-011-9473-z","volume":"173","author":"M Del, Poeta","year":"2012","unstructured":"Del, Poeta, M. & Casadevall, A. Ten challenges on Cryptococcus and cryptococcosis. Mycopathologia 173, 303\u2013310 (2012).","journal-title":"Mycopathologia"},{"key":"66094_CR21","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.4049\/jimmunol.1202526","volume":"190","author":"LB Rosen","year":"2013","unstructured":"Rosen, L. B. et al. Anti-GM-CSF\u2002autoantibodies\u2002in\u2002patients\u2002with\u2002cryptococcal meningitis. J. Immunol. 190, 3959\u20133966 (2013).","journal-title":"J. Immunol."},{"key":"66094_CR22","doi-asserted-by":"publisher","first-page":"e00912","DOI":"10.1128\/mBio.00912-14","volume":"5","author":"T Saijo","year":"2014","unstructured":"Saijo, T. et al. Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients. MBio 5, e00912\u201314 (2014).","journal-title":"MBio"},{"key":"66094_CR23","doi-asserted-by":"publisher","first-page":"5755","DOI":"10.4049\/jimmunol.0901638","volume":"184","author":"KS Subramaniam","year":"2010","unstructured":"Subramaniam, K. S. et al. The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans. J. Immunol. 184, 5755\u20135767 (2010).","journal-title":"J. Immunol."},{"key":"66094_CR24","unstructured":"Xie, X. et al. Clinical analysis of pulmonary cryptococcosis in non-HIV patients in south China. Int J Clin Exp Med 8, 3114-9, eCollection (2015)."},{"key":"66094_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2865-z","volume":"17","author":"Q He","year":"2017","unstructured":"He, Q. et al. Clinical features of pulmonary cryptococcosis among patients with different levels of peripheral blood CD4+ T lymphocyte counts. BMC Infect. Dis. 17, 768 (2017).","journal-title":"BMC Infect. Dis."},{"key":"66094_CR26","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jmii.2011.12.005","volume":"45","author":"CH Liao","year":"2012","unstructured":"Liao, C. H. et al. Different presentations and outcomes between HIV-infected and HIV uninfected patients with cryptococcal meningitis. J. Microbiol. Immunol. Infect. 45, 296\u2013304 (2012).","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"66094_CR27","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11046-011-9471-1","volume":"173","author":"C Yuchong","year":"2012","unstructured":"Yuchong, C. et al. Cryptococcosis in China (1985\u20132010): review of cases from Chinese database. Mycopathologia 173, 329\u2013335 (2012).","journal-title":"Mycopathologia"},{"key":"66094_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.idc.2015.10.006","volume":"30","author":"EK Maziarz","year":"2016","unstructured":"Maziarz, E. K. & Perfect, J. R. Cryptococcosis. Infect. Dis. Clin. North. Am. 30, 179\u2013206 (2016).","journal-title":"Infect. Dis. Clin. North. Am."},{"key":"66094_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/liv.12749","volume":"35","author":"C Ferrari","year":"2015","unstructured":"Ferrari, C. HBV and the immune response. Liver Int. 35, 121\u2013128 (2015).","journal-title":"Liver Int."},{"key":"66094_CR30","doi-asserted-by":"publisher","first-page":"a018424","DOI":"10.1101\/cshperspect.a018424","volume":"5","author":"KD Mayer-Barber","year":"2015","unstructured":"Mayer-Barber, K. D. & Barber, D. L. Innate and adaptive cellular immune responses to Mycobacterium tuberculosis infection. Cold Spring Harb. Perspect. Med. 5, a018424 (2015).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"66094_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/jof3040064","volume":"3","author":"L Mukaremera","year":"2017","unstructured":"Mukaremera, L. & Nielsen, K. Adaptive immunity to Cryptococcus neoformans infections. J. Fungi 3, 64 (2017).","journal-title":"J. Fungi"},{"key":"66094_CR32","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1177\/0284185114529105","volume":"56","author":"LX Xie","year":"2015","unstructured":"Xie, L. X., Chen, Y. S., Liu, S. Y. & Shi, Y. X. Pulmonary cryptococcosis: comparison of CT findings in immunocompetent and immunocompromised patients. Acta Radiol. 56, 447\u2013453 (2015).","journal-title":"Acta Radiol."},{"key":"66094_CR33","doi-asserted-by":"publisher","first-page":"e0173858","DOI":"10.1371\/journal.pone.0173858","volume":"12","author":"Z Hu","year":"2017","unstructured":"Hu, Z. et al. Radiological characteristics of pulmonary cryptococcosis in HIV-infected patients. PLoS One 12, e0173858 (2017).","journal-title":"PLoS One"},{"key":"66094_CR34","first-page":"4437","volume":"16","author":"D Wang","year":"2018","unstructured":"Wang, D. et al. Comparative study of primary pulmonary cryptococcosis with multiple nodules or masses by CT and pathology. Exp. Ther. Med. 16, 4437\u20134444 (2018).","journal-title":"Exp. Ther. Med."},{"key":"66094_CR35","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00408-011-9362-8","volume":"190","author":"F Ye","year":"2012","unstructured":"Ye, F. et al. Retrospective analysis of 76 immunocompetent patients with primary pulmonary cryptococcosis. Lung 190, 339\u2013346 (2012).","journal-title":"Lung"},{"key":"66094_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.fgb.2014.10.003","volume":"78","author":"JR Perfect","year":"2015","unstructured":"Perfect, J. R. & Bicanic, T. Cryptococcosis diagnosis and treatment: What do we know now. Fungal Genet. Biol. 78, 49\u201354 (2015).","journal-title":"Fungal Genet. Biol."},{"key":"66094_CR37","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ccm.2017.04.007","volume":"38","author":"K Skolnik","year":"2017","unstructured":"Skolnik, K., Huston, S. & Mody, C. H. Cryptococcal\u2002lung\u2002infections. Clin. Chest Med. 38, 451\u2013464 (2017).","journal-title":"Clin. Chest Med."},{"key":"66094_CR38","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1086\/374557","volume":"36","author":"JR Perfect","year":"2003","unstructured":"Perfect, J. R. et al. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin. Infect. Dis. 36, 1122\u20131131 (2003).","journal-title":"Clin. Infect. Dis."},{"key":"66094_CR39","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.1128\/AAC.00376-07","volume":"51","author":"LR Martinez","year":"2007","unstructured":"Martinez, L. R., Ntiamoah, P., G\u00e1cser, A., Casadevall, A. & Nosanchuk, J. D. Voriconazole inhibits melanization in Cryptococcus neoformans. Antimicrob. Agents Chemother. 51, 4396\u20134400 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"key":"66094_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/mmy.40.1.21.26","volume":"40","author":"T Chiller","year":"2002","unstructured":"Chiller, T., Farrokhshad, K., Brummer, E. & Stevens, D. A. Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans. Med. Mycol. 40, 21\u201326 (2002).","journal-title":"Med. Mycol."},{"key":"66094_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1128\/JCM.01747-08","volume":"47","author":"MA Pfaller","year":"2009","unstructured":"Pfaller, M. A. et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J. Clin. Microbiol. 47, 117\u2013123 (2009).","journal-title":"J. Clin. Microbiol."},{"key":"66094_CR42","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/jac\/dki393","volume":"56","author":"A Perkins","year":"2005","unstructured":"Perkins, A. et al. Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans. J. Antimicrob. Chemother. 56, 1144\u20131147 (2005).","journal-title":"J. Antimicrob. Chemother."},{"key":"66094_CR43","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1128\/AAC.47.10.3361-3364.2003","volume":"47","author":"P Schwarz","year":"2003","unstructured":"Schwarz, P., Dromer, F., Lortholary, O. & Dannaoui, E. In vitro interaction of flucytosine with conventional and new antifungals against Cryptococcus neoformans clinical isolates. Antimicrob. Agents Chemother. 47, 3361\u20133364 (2003).","journal-title":"Antimicrob. Agents Chemother."},{"key":"66094_CR44","doi-asserted-by":"crossref","unstructured":"Fisher, J. F., Valencia-Rey, P. A. & Davis, W. B. Pulmonary cryptococcosis in the immunocompetent patient-many questions, some answers. Open Forum Infect Dis 3, ofw167 (2016).","DOI":"10.1093\/ofid\/ofw167"},{"key":"66094_CR45","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1136\/pgmj.2009.084418","volume":"86","author":"M Roy","year":"2010","unstructured":"Roy, M. & Ellis, S. Radiologic diagnosis and follow-up of pulmonary tuberculosis. Postgrad. Med. J. 86, 663\u2013674 (2010).","journal-title":"Postgrad. Med. J."},{"key":"66094_CR46","first-page":"438","volume":"19","author":"T Suwatanapongched","year":"2013","unstructured":"Suwatanapongched, T., Sangsatra, W., Boonsarngsuk, V., Watcharananan, S. P. & Incharoen, P. Clinical and radiologic manifestations of pulmonary cryptococcosis in immunocompetentpatients and their outcomes after treatment. Diagn. Interv. Radiol. 19, 438\u2013446 (2013).","journal-title":"Diagn. Interv. Radiol."},{"key":"66094_CR47","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3348\/kjr.2010.11.4.407","volume":"11","author":"KD Song","year":"2010","unstructured":"Song, K. D. et al. Pulmonary cryptococcosis: imaging findings in 23 non-AIDS patients. Korean J. Radiol. 11, 407\u2013416 (2010).","journal-title":"Korean J. Radiol."},{"key":"66094_CR48","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1378\/chest.129.2.333","volume":"29","author":"WC Chang","year":"2006","unstructured":"Chang, W. C. et al. Pulmonary cryptococcosis: comparison of clinical and radiographic characteristics in immunocompetent and immunocompromised patients. Chest 29, 333\u2013340 (2006).","journal-title":"Chest"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66094-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66094-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66094-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T07:03:59Z","timestamp":1670310239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66094-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,10]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["66094"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-66094-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,10]]},"assertion":[{"value":"16 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9387"}}